Tactical Allocation ChannelHealthcare ETFs Strengthen on Hopes of Combating CoronavirusBy Max ChenMarch 30, 2020
Disruptive Technology ChannelA Q&A with Trusted Experts to Help Clarify the UncertaintyBy Max ChenMarch 26, 2020
Disruptive Technology ChannelArtificial Intelligence is Helping Doctors Track the CoronavirusBy Ben HernandezMarch 9, 2020
Disruptive Technology ChannelETFs to Tap into Disruptive Technologies That Can Revolutionize the WorldBy Max ChenMarch 2, 2020
Disruptive Technology ChannelA Targeted Biotech ETF Is Brushing Off the SellingBy Max ChenFebruary 27, 2020
Thematic Investing ChannelPrognosis For This China ETF Is Very Healthy IndeedBy Tom LydonFebruary 20, 2020
Core Equity ChannelDon’t Overlook Healthcare Sector ETFs Even in an Election YearBy Max ChenFebruary 17, 2020
Core Equity ChannelSmall-Cap Health Care ETF Has Been Producing Healthy ReturnsBy Max ChenFebruary 12, 2020
Disruptive Technology ChannelBiotech ETFs Are Not Riding the Wave from Coronavirus PanicBy Max ChenJanuary 24, 2020
Disruptive Technology ChannelTargeted ETFs to Hone in on Innovative Growth Ideas for 2020By Max ChenJanuary 23, 2020
Thematic Investing ChannelPick and Choose Your Sector ETF Exposures During an Election YearBy Max ChenJanuary 22, 2020
Disruptive Technology ChannelBig Ideas: Technological Breakthroughs Investors Shouldn’t Miss in 2020By Max ChenJanuary 22, 2020
Disruptive Technology ChannelHealthcare, Technology ETFs for Dividend Growth OpportunitiesBy Max ChenJanuary 10, 2020
Core Equity ChannelIs There Too Much Froth in the Safe, Steady Healthcare Sector?By Ben HernandezJanuary 9, 2020
Disruptive Technology ChannelActively Managed ETFs Provide Forward-Looking StrategiesBy Max ChenDecember 19, 2019
InvestingBiotech ETFs Slip as Trump Administration Pushes for Cheap Drug ImportsBy Max ChenDecember 18, 2019
